|
 |
Switching Breast Cancer Drugs May Boost Survival |
| TUESDAY, Feb. 13 (HealthDay News) -- Switching to newer breast cancer drugs, called aromatase inhibitors, after two to three years of treatment with tamoxifen may extend disease-free survival and slightly reduce the risk of death in women who\'ve b |
|
|
Health Tip: Side Effects of Birth Control Pills |
| (HealthDay News) -- While many women take birth control pills without incident, these drugs can produce side effects, especially when a woman\'s body adjusts to the hormonal changes they cause. Here is a list of the most common side effects of birth |
|
|
Gene Variant Lowers Risk of Breast Cancer |
| MONDAY, Feb. 12 (HealthDay News) -- Extensive genetic analysis has uncovered a gene variant that cuts the risk of breast cancer by 10 percent, scientists say. Angela Cox, senior lecturer at the Institute of Cancer Studies at the University of Sheffi |
|
|
Newer Drugs Beat Tamoxifen for Breast Cancer Survival |
| MONDAY, Feb. 12 (HealthDay News) -- Postmenopausal breast cancer patients who switch from tamoxifen therapy to another type of drug, called an aromatase inhibitor, may gain a significant boost in survival, Italian research shows. Women in the study |
|
|
Study Confirms Link Between Hormone, Insulin-Producing Cells |
| FRIDAY, Feb. 9 (HealthDay News) -- A neuropeptide called melanin concentrating hormone (MCH) plays a role in the growth of insulin-producing beta cells in the pancreas and the secretion of insulin, a new study finds. MCH is found in the brain and |
|
|
Experimental Psoriasis Drug Produces Impressive Results |
| WEDNESDAY, Feb. 7 (HealthDay News) -- A new monoclonal antibody drug produced dramatic improvements in psoriasis patients. In some cases, the improvements lasted up to six months after just one injection, researchers report. \"The studies that we ca |
|
|
New Drug Helps Ease Psoriasis |
| TUESDAY, Feb. 13 (HealthDay News) -- Many patients with moderate to severe chronic psoriasis showed significant improvement after treatment with Humira (adalimumab), according to a study presented at the recent annual meeting of the American Academy |
|
|
For Drivers, Skin Cancer Is Often One-Sided |
| FRIDAY, Feb. 2 (HealthDay News) -- People who spend a lot of time behind the wheel may be motoring their way to an increased risk of skin cancer on the left side of their body, U.S. researchers report. \"Since previous scientific findings have show |
|
|
A Little Sun Might Shield Against Skin Cancer |
| MONDAY, Jan. 29 (HealthDay News) -- It\'s a puzzle to scientists, but a new study suggests that the main cause of deadly skin cancer -- sunlight -- might also help protect against the disease. The key could lie in the amount of ultraviolet B (UVB) l |
|
|
Psoriasis Often Goes Untreated: Survey |
| FRIDAY, Feb. 2 (HealthDay News) -- Many Americans with chronic moderate or severe psoriasis receive no treatment or inadequate treatment, a new survey from the National Psoriasis Foundation (NPF) shows. The poll also revealed a link between severe p |
|
|
Partnered Learning Boosts Use of Skin Cancer Self-Exams |
| WEDNESDAY, Jan. 17 (HealthDay News) -- Learning skin self-examination with a partner boosts the likelihood people will regularly conduct these exams to help spot skin cancers, a U.S. study finds. The study, published in the January issue of the Arch |
|
